05 Jun 2023 --- Synthetic biology company Debut has secured US$34 million Series B in a funding round led by L’Oréal’s venture capital fund, Business Opportunities for L’Oréal Development (BOLD). As the exclusive beauty investor in the company, L’Oréal’s investment will scale the biotech’s manufacturing platform to meet the growing demand for “breakthrough ingredients” to be used in cosmetics, skin care and packaging.
